Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
November 10, 2023
Tickers
BIIB
LLY
RHHBY
Tags
Market News
LLY
Recent Press Releases
From
Motley Fool
Regeneron's Skin Drugs Propel Revenue In Q3, Witnesses Strong Demand For Higher Dose Version Of Flagship Eye Drug
November 02, 2023
Tickers
REGN
RHHBY
Tags
Market News
Benzinga
Biotech
From
Benzinga
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
October 31, 2023
Tickers
RHHBF
RHHBY
RHHVF
SRPT
Tags
News
why it's moving
Briefs
From
Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
Tickers
BHC
CAH
CVS
NVS
Tags
Health Care
Eye care
RADCQ
From
Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
October 28, 2023
Tickers
LLY
PFE
RHHBY
Tags
Market News
LLY
Recent Press Releases
From
Motley Fool
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
October 24, 2023
Tickers
PFE
RHHBY
ROIV
XBI
Tags
Market News
XBI
Recent Press Releases
From
Motley Fool
Why Is Roivant Sciences (ROIV) Stock Up Today?
October 23, 2023
Tickers
PFE
RHHBY
ROIV
Tags
Market News
NASDAQ:ROIV,OTCMKTS:RHHBY,NYSE:PFE
Today's Market
From
InvestorPlace
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal
October 23, 2023
Tickers
PFE
RHHBF
RHHBY
ROIV
Tags
Health Care
ROIV
Eurasia
From
Benzinga
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
October 23, 2023
Tickers
PFE
RHHBY
ROIV
Tags
PFE
ROIV
RHHBY
From
MarketWatch
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
Tickers
BMY
BNTX
PFE
REGN
Tags
SGEN
Market News
PFE
From
Motley Fool
PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
October 19, 2023
Tickers
PTCT
RHHBY
RPRX
SPX
Tags
PTCT
RPRX
RHHBY
From
MarketWatch
Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products
October 19, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Benzinga
Market News
Health Care
From
Benzinga
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?
October 17, 2023
Tickers
GLUE
RHHBF
RHHBY
RHHVF
Tags
why it's moving
Briefs
News
From
Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
Tickers
AZN
BMY
MRK
RHHBY
Tags
News
Briefs
RHHBY
From
Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
October 16, 2023
Tickers
BMY
NVO
PRTA
RHHBY
Tags
Movers
why it's moving
News
From
Benzinga
Tempest Therapeutics shares head back to earth after 4,000% gain
October 12, 2023
Tickers
RHHBY
SPX
TPST
Tags
TPST
RHHBY
SPX
From
MarketWatch
TPST Stock: 7 Things to Know About Tempest Therapeutics
October 11, 2023
Tickers
RHHBY
TPST
Tags
RHHBY
TPST
Today's Market
From
InvestorPlace
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
October 11, 2023
Tickers
BIIB
DGX
ESALY
LH
Tags
BIIB
Health Care Services
Health Care
From
Benzinga
Tempest Therapeutics’ stock jumps 1,900% as liver-cancer treatment shows promise
October 11, 2023
Tickers
RHHBY
SPX
TPST
Tags
TPST
RHHBY
SPX
From
MarketWatch
Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update
October 04, 2023
Tickers
RHHBY
SNY
TLSA
Tags
General
RHHBY
Partner Content
From
Benzinga
Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich
October 03, 2023
Tickers
CRSP
MRNA
PSTX
RHHBY
Tags
PSTX
VRTX
Market News
From
InvestorPlace
2 Cathie Wood Stocks That Could Deliver Exponential Returns
October 02, 2023
Tickers
ARKK
EXAS
NVDA
RHHBY
Tags
NVDA
Market News
RHHBY
From
Motley Fool
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
Tickers
ALNY
AZN
IONS
NVS
Tags
Market News
Benzinga
Contracts
From
Benzinga
AI To Revolutionize Clinical Trials And Diagnostics
September 22, 2023
Tickers
AMGN
BAYRY
MYNZ
NVS
Tags
Penny Stocks
contributors
Benzinga
From
Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
Tickers
A
ABT
BDX
BRKR
Tags
OSUR
DGX
Health Care
From
Benzinga
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
September 13, 2023
Tickers
ALNY
ARKG
BBIO
RHHBY
Tags
RHHBY
ALNY
Stocks to Buy
From
InvestorPlace
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
September 12, 2023
Tickers
BLUE
RHHBY
RXRX
Tags
RHHBY
Recent Press Releases
BAYR/Y
From
Motley Fool
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
Tickers
ILMN
JNJ
ME
NVS
Tags
REGN
Small Cap
Biotech
From
Benzinga
Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data
September 08, 2023
Tickers
NVDA
RHHBY
RXRX
Tags
RXRX
RHHBY
NVDA
From
MarketWatch
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
Tickers
ALNY
IONS
RHHBF
RHHBY
Tags
Biotech
Health Care
Market News
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.